Letter to the New York stem cell research program ethics board
By Jesse Reynolds and Susan Fogel
| 01. 21. 2009
Dear Members of the NYSTEM Ethics Board:
We are supporters of embryonic stem cell research who wish to express our deep concerns about your upcoming consideration of permitting payments to women to provide eggs for stem cell research. Multiple egg extraction poses risks to women's health without a clear and demonstrable scientific rationale, and allowing payments for eggs is contrary to the guidelines set by the National Academies of Science.
The extraction of eggs poses nontrivial health risks for the women. The drug most often used to shut down the ovaries, Lupron, can cause side effects, including severe joint pain, difficulty breathing, chest pain, depression, amnesia, hypertension, and asthma. The drugs used to hyperstimulate the ovaries can lead to Ovarian Hyperstimulation Syndrome, which in the most severe cases can lead to hospitalization and, rarely, death. The Institute of Medicine report, Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research, makes clear how little is known about the full risks of multiple egg extraction. In fact, the limited research has been done on infertile women, and therefore virtually...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...